NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

TerminatedPhase 4

Sponsor: CANDLE-KIT Trial Study Group

Conditions: Kidney Transplantation, Anemia, Vitamin D Deficiency, Renal Insufficiency, Chronic

Interventions: High Hb target, cholecalciferol

Countries: Japan

The purpose of this study is to evaluate the effect of anemia correction and vitamin D supplementation in kidney transplant recipients.

Eligibility overview

Sex: ALL

Age: 20 Years to 79 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* ≥15 and \<60 ml/min per 1.73 m2 of estimated glomerular filtration rate
* Transplanted allograft kidney at least 1 year before
* \<10.5 g/dL of Hb without iron deficiency (serum ferritin level ≥50 ng/ml) or on erythropoiesis stimulating agents treatment regardless of iron status
* With written informed consent

Exclusion Criteria:

* On anticancer treatment
* History of ischemic stroke or transient ischemic attack
* Corrected serum calcium ≥10.5 mg/dL
* HIV virus infection
* Anticipated refractory hypertension by using epoetin beta pegol
* In pregnancy and lactation
* Current use of native vitamin D supplement
* Patients ineligible according to the investigator's judgement

Locations (1)

Suita, Osaka, Japan